Method for inhibiting zophobas morio black wasting disease
AssigneeRutgers, The State University of New Jersey
InventorsJason KAELBER, Judit PENZES
Life of this patent
Estimating the term…
Loading patent…
AssigneeRutgers, The State University of New Jersey
InventorsJason KAELBER, Judit PENZES
Estimating the term…
A reared colony of larval superworms (Zophobas morio) experienced the swift and unexplained death of about 90% of its population. From dead larvae, a high-abundance virus was isolated and identified as a novel densovirus, Zophobas morio black wasting virus (ZmBWV), by means of cryo-electron microscopy. Strains of this virus were sequenced and an engineered vaccine virus sequence was developed. The black wasting disease was replicated in larvae by inoculation with pathogenic strains of ZmBWV. Larvae were inoculated with a non-pathogenic strain as prophylaxis and later challenged by inoculation with a pathogenic strain. The larvae that received a non-pathogenic strain were protected from later disease and death but the larvae that received a saline solution were not. The invention provides methods and vaccine products to inhibit morbidity and mortality of ZmBWWV in darkling beetle larvae.
A method of inhibiting Zophobas morio black wasting disease morbidity and mortality in a darkling beetle colony in need thereof, comprising:
A prophylactic vaccine composition, comprising the corpses of Z. morio larvae infected with a non-pathogenic strain of densovirus selected from the group consisting of SEQ ID NO:2, SEQ ID NO:3, SEQ ID NO:4, SEQ ID NO:5, SEQ ID NO:6, SEQ ID NO:7, SEQ ID NO:8, SEQ ID NO:9, and any combination thereof.
A prophylactic vaccine composition, comprising the corpses of darkling beetle larvae infected with a strain of ZmBWV that is isolated from Tenebrio molitor and does not cause mortality in the recipient species at a dose of 109 genomes.
A prophylactic vaccine composition comprising purified virions of a non-pathogenic strain of densovirus and a pharmaceutically acceptable medium, wherein the sequence identity between the non-pathogenic strain of densovirus and strain NJ2-molitor (SEQ ID NO:
A prophylactic vaccine composition comprising:
A prophylactic vaccine composition, comprising one or more nonpathogenic densovirus strain, wherein the NS3 canonical ATG start codon is mutated, truncating the NS3 protein to fewer than 200 amino acids, instead of the length of 221 residues in the pathogenic, highly virulent strain UT-morio (SEQ ID NO:
Dependencies are inferred from the claim text.